首页> 外文期刊>Chemweek's business daily >ICL to acquire Prolactal
【24h】

ICL to acquire Prolactal

机译:ICL收购Prolactal

获取原文
获取原文并翻译 | 示例
           

摘要

Israel Chemicals Ltd. (ICL; Tel Aviv) says that its food specialties business unit has entered into a share purchase agreement to acquire Prolactal (Hartberg, Austria) and its subsidiary, Rovita (Engelsberg, Germany). Prolactal is a leading European producer of dairy proteins and other ingredients for the food and beverage industries. Financial details of the deal were not disclosed. Prolactal is a privately-held company with annual sales of about ?100 million ($113 million), and it produces and sells an extensive range of functional dairy proteins used broadly in the beverage, dairy and meat industries to stabilize and improve the nutrition of beverages and foods processed under a variety of conditions, ICL says. The transaction is expected to close during the first quarter of 2015, subject to the receipt of regulatory approvals in Austria and Germany.
机译:以色列化工有限公司(ICL;特拉维夫)表示,其食品特殊业务部门已达成购股协议,以收购Prolactal(奥地利哈特贝格)及其子公司Rovita(德国恩格斯贝格)。 Prolactal是欧洲领先的食品和饮料行业乳制品蛋白和其他成分生产商。交易的财务细节没有透露。 Prolactal是一家私有公司,年销售额约为1亿欧元(1.13亿美元),它生产和销售广泛用于饮料,乳制品和肉类行业的稳定功能蛋白,以稳定和改善饮料营养ICL说,以及在各种条件下加工的食品。该交易有望在2015年第一季度完成,但要获得奥地利和德国的监管机构批准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号